Maintenance of telomeres requires both DNA replication and telomere 'capping' by shelterin. These two processes use two singlestranded DNA (ssDNA)-binding proteins, replication protein A (RPA) and protection of telomeres 1 (POT1). Although RPA and POT1 each have a critical role at telomeres, how they function in concert is not clear. POT1 ablation leads to activation of the ataxia telangiectasia and Rad3-related (ATR) checkpoint kinase at telomeres 1,2 , suggesting that POT1 antagonizes RPA binding to telomeric ssDNA. Unexpectedly, we found that purified POT1 and its functional partner TPP1 are unable to prevent RPA binding to telomeric ssDNA efficiently. In cell extracts, we identified a novel activity that specifically displaces RPA, but not POT1, from telomeric ssDNA. Using purified protein, here we show that the heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) recapitulates the RPA displacing activity. The RPA displacing activity is inhibited by the telomeric repeat-containing RNA (TERRA) in early S phase, but is then unleashed in late S phase when TERRA levels decline at telomeres 3 . Interestingly, TERRA also promotes POT1 binding to telomeric ssDNA by removing hnRNPA1, suggesting that the reaccumulation of TERRA after S phase helps to complete the RPA-to-POT1 switch on telomeric ssDNA. Together, our data suggest that hnRNPA1, TERRA and POT1 act in concert to displace RPA from telomeric ssDNA after DNA replication, and promote telomere capping to preserve genomic integrity.
Maintenance of telomeres requires both DNA replication and telomere 'capping' by shelterin. These two processes use two singlestranded DNA (ssDNA)-binding proteins, replication protein A (RPA) and protection of telomeres 1 (POT1). Although RPA and POT1 each have a critical role at telomeres, how they function in concert is not clear. POT1 ablation leads to activation of the ataxia telangiectasia and Rad3-related (ATR) checkpoint kinase at telomeres 1,2 , suggesting that POT1 antagonizes RPA binding to telomeric ssDNA. Unexpectedly, we found that purified POT1 and its functional partner TPP1 are unable to prevent RPA binding to telomeric ssDNA efficiently. In cell extracts, we identified a novel activity that specifically displaces RPA, but not POT1, from telomeric ssDNA. Using purified protein, here we show that the heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) recapitulates the RPA displacing activity. The RPA displacing activity is inhibited by the telomeric repeat-containing RNA (TERRA) in early S phase, but is then unleashed in late S phase when TERRA levels decline at telomeres 3 . Interestingly, TERRA also promotes POT1 binding to telomeric ssDNA by removing hnRNPA1, suggesting that the reaccumulation of TERRA after S phase helps to complete the RPA-to-POT1 switch on telomeric ssDNA. Together, our data suggest that hnRNPA1, TERRA and POT1 act in concert to displace RPA from telomeric ssDNA after DNA replication, and promote telomere capping to preserve genomic integrity.
RPA binds ssDNA in a non-sequence specific manner 4 , whereas POT1 specifically recognizes ssDNA consisting of the telomeric repeats 5 . RPA plays a key role in DNA replication and activation of the ATR checkpoint 6 , and POT1 suppresses ATR activation at telomeres 1, 2 ( Supplementary Fig. 1 ). In both yeast and humans, RPA associates with telomeres during S phase of the cell cycle [7] [8] [9] , and is implicated in telomere maintenance [10] [11] [12] . Furthermore, ATR transiently associates with telomeres and suppresses telomere instability 7, 10, 13 . These findings raise the question of how the bindings of POT1 and RPA to telomeric ssDNA are orchestrated and, furthermore, how the interplay between POT1 and RPA affects DNA replication and ATR activation at telomeres. Double-stranded DNA (dsDNA) with ssDNA overhangs activates ATR in human cell extracts 14 . To investigate how ATR activation is suppressed at telomeres, we tested whether telomeric ssDNA overhangs affect ATR activation in this assay. Resected dsDNA of random sequences, but not resected telomeric dsDNA, efficiently induced the phosphorylation of RPA2 by ATR ( Supplementary Fig. 2 ) 14 , suggesting that telomeric ssDNA overhangs do not support efficient ATR activation in cell extracts.
The absence of ATR activation by telomeric ssDNA suggests that POT1 may prevent RPA binding to telomeric ssDNA 2 . POT1 and TPP1 function as heterodimers in cells, and the complex binds to telomeric ssDNA more efficiently than POT1 alone 15, 16 . In gel-shift assays, the POT1-TPP1 complexes purified from insect or human cells and the RPA purified from Escherichia coli efficiently bound to a telomeric ssDNA probe ( Fig. 1a and Supplementary Fig. 3a, b ). POT1-TPP1 exhibited lower affinity for telomeric ssDNA than RPA ( Supplementary Fig. 3a ). When POT1-TPP1 and RPA were co-incubated with the probe, the RPA-ssDNA complex was readily detected, whereas no POT1-containing complexes were observed ( Fig. 1a and Supplementary Fig. 3b ). In pull-down assays using biotinylated telomeric ssDNA (ssTEL), RPA also outcompeted POT1-TPP1 for binding to ssTEL ( Fig. 1b and Supplementary Fig. 3c ). Thus, RPA, which is more abundant than POT1-TPP1 in cells 4, 17 , outcompetes POT1-TPP1 for binding to telomeric ssDNA when present at similar concentrations as POT1-TPP1. The E. coli ssDNA-binding protein only modestly reduced POT1 binding to ssTEL ( Supplementary Fig. 3c ), suggesting that the ability to outcompete POT1-TPP1 is unique to RPA.
The ability of RPA to outcompete POT1-TPP1 raises the question of how ATR activation is suppressed in cell extracts. Purified RPA bound to ssTEL and mutated telomeric repeats (ssMUT) efficiently ( Fig. 1c ). In stark contrast to purified RPA, the endogenous RPA in HeLa whole-cell extracts (WCEs) was largely excluded from ssTEL; however, it still associated with ssMUT ( Fig. 1c ). The sequence-specific exclusion of RPA from ssTEL in WCEs suggests that RPA may be outcompeted by other proteins or actively displaced from telomeric ssDNA.
To assess if RPA is actively displaced from ssTEL, we pre-coated ssTEL and ssMUT with RPA then incubated them in extracts. The levels of RPA on ssTEL gradually declined with increasing concentrations of WCEs from HeLa, HEK293E, U2OS and MEF cells ( Fig. 1d and Supplementary Fig. 4a ). In addition, HeLa nuclear extracts, but not the cytoplasmic extracts, efficiently displaced RPA from ssTEL ( Supplementary Fig. 4b ). In marked contrast to the RPA on ssTEL, the RPA bound to ssMUT remained constant regardless of WCE concentrations ( Fig. 1d ). When POT1-coated ssTEL was incubated in extracts, POT1 remained stably bound to ssTEL even in high concentrations of WCEs ( Fig. 1e ). Furthermore, RPA was rapidly displaced from ssTEL within 5 min, whereas no POT1 was displaced after 60 min ( Supplementary Fig. 4c ). Thus, the activity that displaces RPA from telomeric ssDNA is sequence-specific, protein-specific and localized within the nucleus.
The specific displacement of RPA, but not POT1, from telomeric ssDNA prompted us to test if POT1 is the RPA displacing factor. When incubated with RPA-ssTEL, POT1-TPP1 did not significantly reduce the levels of ssTEL-bound RPA ( Supplementary Fig. 5a ). To identify the RPA displacing factors, we sought to capture the RPA displacing activity from extracts using RPA-ssTEL as bait. The proteins captured and eluted from RPA-ssTEL, but not RPA-ssMUT, recapitulated the RPA displacing activity ( Fig. 2a ). Mass spectrometry analysis of the proteins specifically captured by RPA-ssTEL identified hnRNPA1 and hnRNPA2/B1 ( Supplementary Fig. 5b , c), both of which are known to bind telomeric ssDNA 18, 19 . The presence of hnRNPA1 and A2/B1 in the eluted fraction with RPA displacing activity was confirmed by western blot (Fig. 2b ). Moreover, hnRNPA1 and A2/B1 gradually bound to ssTEL as RPA was displaced in WCEs ( Fig. 2c ). These results suggest that hnRNPA1 and A2/B1 may play a role in RPA displacement.
hnRNPA1 has been implicated in telomere maintenance 20, 21 . Extracts from hnRNPA1 knockdown cells exhibited reduced activity in RPA displacement ( Supplementary Fig. 6a ). Purified hnRNPA1 efficiently displaces RPA from ssTEL, but not ssMUT ( Fig. 2d ). Furthermore, hnRNPA1 did not displace POT1 from ssTEL ( Fig. 2e ). hnRNPA1 only displaces RPA from ssTEL containing four or more telomeric repeats ( Supplementary Fig. 6b ), indicating that a DNA length-dependent binding mode of hnRNPA1 may be needed to displace RPA 22 . Given that hnRNPA1 and A2/B1 are highly homologous in the RRM domains that bind telomeric ssDNA, both of these hnRNPs may contribute to RPA displacement. hnRNPA1 not only binds telomeric ssDNA but also TERRA [23] [24] [25] [26] . To test if TERRA affects the ability of hnRNPA1 to displace RPA from ssTEL, we added increasing concentrations of TERRA or control RNA to nuclear extracts , then incubated the extracts with RPA-ssTEL. RPA displacement was virtually abolished by TERRA, but not control RNA (Fig. 3a) . The RPA displacing activity captured by RPA-ssTEL was also specifically inhibited by TERRA ( Fig. 3b ). Furthermore, the ability of purified hnRNPA1 to bind ssTEL and to displace RPA from ssTEL was specifically inhibited by TERRA ( Fig. 3c and Supplementary Fig. 6c ). Thus, TERRA is a potent inhibitor of the RPA displacing activity of hnRNPA1. with RPA were incubated with nuclear extracts (NE). After the incubation, the proteins bound to DNA were retrieved, eluted and applied to RPA-coated ssTEL or ssMUT (see Supplementary Methods). After the second incubation, the remaining RPA2 on DNA was analysed by western blot. b, Proteins captured by RPA-ssTEL or RPA-ssMUT and eluted by salt were analysed by western blot using antibodies to hnRNPA1, hnRNPA2/B1 and TRF2. c, RPAcoated ssTEL (0.8 nM) was incubated with increasing concentrations of WCEs (0.06, 0.24, 0.96 mg ml 21 ). The hnRNPA1 and hnRNPA2/B1 bound to DNA and the remaining RPA2 on DNA were analysed by western blot. d, RPA-coated ssTEL or ssMUT (0.8 nM) was incubated with increasing concentrations of purified hnRNPA1 (2.4, 4.8, 7.2 nM). The remaining RPA2 on DNA was analysed as in a. e, POT1-coated ssTEL (0.8 nM) was incubated with increasing concentrations of purified hnRNPA1 (2.4, 4.8, 7.2 nM).
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If hnRNPA1 displaces RPA from telomeric ssDNA, how can POT1 bind to telomeric ssDNA? Given that hnRNPA1 has affinity for both telomeric ssDNA and TERRA, the presence of TERRA at telomeres may promote the dissociation of hnRNPA1 from telomeric ssDNA. Indeed, when hnRNPA1-coated ssTEL was incubated with TERRA, hnRNPA1 was stripped from ssTEL ( Fig. 3d) , showing that hnRNPA1 binds telomeric ssDNA dynamically. Furthermore, when hnRNPA1-ssTEL was incubated with TERRA and POT1-TPP1, POT1 efficiently bound to ssTEL as hnRNPA1 was removed by TERRA ( Fig. 3e ).
The in vitro results above suggest that the initial displacement of RPA from telomeric ssDNA may be performed by hnRNPs when TERRA levels are low at telomeres ( Fig. 3f ). However, if TERRA levels rise at telomeres, hnRNPA1 may shuttle between telomeric ssDNA and TERRA dynamically. In this situation, both RPA and POT1 may have the chance to bind telomeric ssDNA. Because hnRNPA1 only displaces RPA, but not POT1, this dynamic process will eventually promote POT1 occupancy at telomeric ssDNA.
This model raises the possibility that the RPA displacing activity may be regulated by TERRA during the cell cycle. To test this, we generated WCEs from cells in G1, early S, late S and M phases of the cell cycle. RPA was more efficiently displaced in the late S-and M-phase extracts than in the G1-and early S-phase extracts ( Fig. 4a and Supplementary Fig. 7a, b) . Thus, the RPA displacing activity is low in G1 and early S phase, but upregulated in late S phase.
If TERRA inhibits the RPA displacing activity, its levels should inversely correlate with the activity. Furthermore, removal of TERRA in early S phase should alleviate the inhibition. Indeed, a recent study showed that TERRA levels significantly decrease in late S phase and increase again after S phase 3 . Consistently, telomeric TERRA foci declined as cells progressed from early to late S phase ( Fig. 4b and Supplementary Fig. 7c, d ). In addition, RNase A treatment of early S-phase extracts significantly enhanced the RPA displacing activity ( Supplementary Fig. 7e ). Together, these results suggest that TERRA inhibits RPA displacement in early S phase, and its decline in late S phase may provide a window for RPA displacement.
The model above also predicts that hnRNPs are necessary for RPA displacement from telomeres. Depletion of hnRNPA1 using two independent short interfering RNA (siRNAs) significantly increased the fraction of cells displaying RPA foci ( Fig. 4c and Supplementary Fig.  8a-d) . Notably, a fraction of the RPA foci in hnRNPA1 knockdown cells closely associated with TRF2 foci. Furthermore, increased RPA binding at telomeres was detected in hnRNPA1 knockdown cells by chromatin immunoprecipitation (Fig. 4d ). In synchronized hnRNPA1 knockdown cells, RPA binding to telomeres was enhanced in early S phase ( Supplementary Fig. 9a, b ), indicating that even during this period some hnRNPA1 remains free from TERRA and limits RPA binding to telomeres 9 . In late S/G2, RPA still declined at telomeres in hnRNPA1 knockdown cells, possibly owing to the redundancy among hnRNPs.
If the displacement of RPA by hnRNPA1 is a prerequisite for POT1 binding, POT1 should be needed for RPA exclusion after late S phase. To assess this possibility, we treated cells with POT1 siRNA and synchronized the cells with thymidine as POT1 levels declined (Supplementary Fig. 10a, b ). After POT1 knockdown cells and control cells were synchronously released, RPA foci appeared in both cell populations ( Fig. 4e ). As control cells entered G2, RPA foci rapidly declined. In contrast, the POT1 knockdown cells containing RPA foci that colocalized with TRF2 continued to increase. Concomitantly, modest Chk1 phosphorylation was detected in POT1 knockdown cells ( Supplementary Fig. 10c ). Thus, reduction of POT1 compromises the exclusion of RPA from telomeres after replication 27 .
During early to middle S phase, TERRA sequesters hnRNPs and allows RPA to bind telomeric ssDNA at replication forks or telomere ends ( Supplementary Fig. 1 ). When TERRA levels decline in late S phase, hnRNPs are unleashed to displace RPA from telomeric ssDNA. The dynamic binding of hnRNPs to telomeric ssDNA is gradually antagonized by TERRA when TERRA reaccumulates at telomeres, providing a window for both RPA and POT1 to bind. Because only POT1, but not RPA, binds to telomeric ssDNA irreversibly in the presence of hnRNPs, this dynamic process favours the formation of 
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POT1-coated telomeric ssDNA. Unlike RPA, POT1 kinks telomeric ssDNA and induces its self-recognition 28, 29 . These unique properties of POT1 may confer resistance to hnRNP-mediated displacement. The cell-cycle-regulated RPA displacement may allow RPA to transiently associate with telomeric ssDNA during replication, and prevent persistent ATR activation at telomeres after S phase. Once coated by POT1, telomeric ssDNA may remain capped until the arrival of replication forks in the next S phase. Together, TERRA and hnRNPs orchestrate a cell-cycle-regulated RPA-to-POT1 switch on telomeric ssDNA, ensuring orderly telomere replication and capping.
METHODS SUMMARY
To analyse the bindings of RPA and POT1-TPP1 to ssDNA, biotinylated ssDNA was attached to streptavidin-coated magnetic beads. Biotinylated ssDNA (1 pmol) was incubated with purified protein in 500 ml of binding buffer (10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 10 mg ml 21 BSA, 10% glycerol, 0.05% NP-40). Supplementary Methods) . The remaining RPA2 on ssTEL was analysed after incubation. Cyclin A and phospho-histone H3 serve as cell-cycle markers, and histone H4 as a loading control. b, TERRA was analysed by RNA fluorescence in situ hybridization in HeLa cells after thymidine release. TRF2 serves as a marker of telomeres. c, HeLa cells were treated with hnRNPA1 siRNA or mock treated, then immunostained with antibodies to RPA2 and TRF2 (left panel). The cells with RPA foci (.5) were quantified (right panel). Mean 6 s.d., n 5 3 for mock and sihnRNPA1-1, n 5 2 for sihnRNPA1-2. d, Chromatin immunoprecipitation (ChIP) of RPA was performed with two different RPA2 antibodies (Ab). The association of RPA with telomeres was analysed by dot blot using a telomere probe and quantified. e, HeLa cells transfected with POT1 or LacZ siRNA were released from a thymidine block. At the indicated times, the G2/M population was determined by FACS ( Supplementary Fig. 10c ). Cells were immunostained for RPA2 and TRF2 (left panel). The cells with RPA foci (.5) were quantified (right panel). Mean 6 s.d., n 5 3.
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METHODS ATR activation. To generate the 800-base-pair (bp) telomeric dsDNA fragment, the pSTY11 plasmid (a gift from T. de Lange) was digested with EcoRI and the excised fragment was gel purified. The 800-bp random sequence dsDNA was generated by PCR and column purified. These dsDNA fragments were incubated with T7 exonuclease for 15 s at room temperature (approximately 23 uC) and flash frozen in an ethanol-dry-ice bath. T7 was inactivated by subsequent incubation at 70 uC for 20 min and DNA fragments were separated on 2% agarose gel to confirm equal resection. The resected DNA fragments were incubated with nuclear extract as previously described 14 . To monitor specifically the phosphorylation of RPA2 by ATR and eliminate the contributions of ataxia telangiectasia mutated (ATM) and DNA-PK to RPA2 phosphorylation, nuclear extracts were pre-treated with 20 mM KU55933 and NU7026 inhibitors for 15 min at 4 uC. The extracts were mixed with the DNA fragments, incubated for 15 min at 37 uC, and RPA phosphorylation was analysed by western blot. Protein purification. The POT1-TPP1 complex was either purified from baculovirus-infected Sf9 cells as previously described 16 , or purified from HEK293E cells as follows. The pCL-Flag-POT1 and pCL-Flag-TPP1 vectors 16 were individually transfected or co-transfected into HEK 293E cells. The cells were collected after 72 h and lysed in the NETN buffer (100 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl (pH 8.0), 0.5% NP-40 and protease inhibitors), sonicated and cleared by centrifugation (10,000g for 10 min). The cleared lysates were incubated with the M2 anti-Flag antibody-conjugated beads at 4 uC for 2 h and eluted with 200 mg ml 21 33 Flag peptide in buffer A (25 mM Tris-HCl (pH 8.0) 100 mM NaCl, 10% glycerol) for 1 h. Recombinant RPA complex was purified from E. coli as previously described 30 . hnRNPA1 pET9d plasmid (a gift from A. Krainer) was transformed into E. coli and expression was induced with IPTG (0.4 mM) for 3 h at 37 uC. The cells were then collected and lysed in binding buffer (10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 10 mg ml 21 BSA, 10% glycerol, 0.05% NP-40). Lysates were sonicated, cleared by centrifugation (10,000g for 10 min) and incubated with ssTEL-(50 mM) conjugated M280 beads (100 ml) for 30 min at room temperature. The ssTEL and associated protein were captured by magnets, washed in binding buffer and eluted with 1 M NaCl for 10 min at 4 uC. The eluted protein was then diluted in binding buffer without salt to bring the final NaCl concentration down to 100 mM. E. coli single-stranded binding protein (SSB) was purchased from Promega.
Gel-shift assay. The 18-nucleotide telomeric ssDNA probe [(TTAGGG) 3 ] was radiolabelled with c-32 P using T4 kinase and purified over a G25 column. The labelled ssDNA was incubated with purified RPA or POT1-TPP1 in binding buffer (10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 10 mg ml 21 BSA, 10% glycerol, 0.05% NP-40) for 30 min at room temperature. The resulting protein-DNA complexes were separated by gel electrophoresis using 0.8% agarose at 140 V for 1.5 h and bands were visualized by autoradiography. DNA-protein binding assay using biotinylated ssDNA. Biotinylated ssTEL [(TTAGGG) 8 ] or ssMUT [(TTTGCG) 8 ] were attached to streptavidin-coated magnetic beads in 10 mM Tris-HCl (pH 8.0), 100 mM NaCl at room temperature for 30 min. To analyse the bindings of purified RPA, POT1-TPP1 and POT1 to ssDNA, biotinylated ssDNA (1 pmol) was incubated with various amounts of purified protein in 500 ml of binding buffer. To analyse the binding of RPA and Flag-POT1 to ssDNA in extracts, biotinylated ssDNA (10 pmol) and various amounts of extracts were added to 500 ml of binding buffer. After incubation for 30 min, the protein-DNA complexes were retrieved with a magnet and washed three times with binding buffer. In the experiments using RPA or POT1 precoated ssDNA, biotinylated ssDNA (1 pmol) was first incubated with purified protein (3.8 pmol) for 30 min at room temperature. The ssDNA pre-coated with RPA or POT1 was retrieved with a magnet and subsequently mixed with increasing concentrations of WCE, nuclear extract or cytoplasmic extract for 30 min at room temperature. For nuclear extract inhibited by addition of TERRA or its derivatives ((UUAGGG) 3 , (CCCAUU) 3 and (UUGGCG) 3 ), extracts were incubated with 1, 2, 5 or 10 pmol RNA for 30 min at 4 uC. For hnRNPA1 binding, RPA-coated ssTEL or ssMUT (0.8 nM), or Flag-POT1coated ssTEL (0.8 nM), were incubated with increasing concentrations of hnRNPA1 purified from E. coli (2.4, 4.8, 7.2 nM) and the proteins remaining on ssTEL were analysed by western blot. For TERRA inhibition, hnRNPA1 was preincubated with increasing concentrations of TERRA (2, 4, 10, 20 nM), or control RNA (UUGGCG) 3 . hnRNPA1 was then incubated with RPA coated ssTEL (0.8 nM). Similarly, to demonstrate that TERRA promotes the dissociation of hnRNPA1 from ssTEL, the ssTEL (0.8 nM) was pre-coated with hnRNPA1 (2.4 nM) and subsequently incubated with increasing concentrations of TERRA (2, 20, 200, 2,000 nM). To demonstrate that TERRA enhances POT1 binding, ssTEL (0.8 nM) was pre-coated with hnRNPA1 (2.4 nM) then incubated with both POT1 (2.4 nM) and increasing concentrations of TERRA (2, 20, 200 nM). In all reactions, the proteins remaining on DNA were analysed by western blot.
Cell synchronization. To follow the progression of cells from S to G2 (Fig. 4b, e ), HeLa cells were synchronized with 2 mM thymidine for 16 h, washed three times with PBS and once with thymidine-free medium, and released into thymidine-free medium. To enrich HeLa cells in S phase of the cell cycle ( Fig. 4a ), cells were either collected after treatment for 16 h with 2 mM thymidine (early S), or collected 4 h after thymidine release (late S). To enrich cells in G1 and M phases, cells were either collected after treatment for 16 h with 0.1 mg ml 21 nocodazole (M), or collected 4 h after nocodazole release (G1). Extract preparation. WCEs were either generated with the NETN buffer as described in the protein purification section, or with the binding buffer used in the DNA binding assays. Nuclear extract and cytoplasmic extract were generated as previously described 3 . To treat extracts with TERRA or its derivative RNA, RNA was added to WCE or nuclear extract in increasing concentrations (1, 2, 5, 10 pmol) and incubated for 30 min on ice. Capture of RPA-displacing activity from extracts. To capture the RPA-displacing activity from extracts, RPA-coated ssTEL was incubated with nuclear extract for 30 min at room temperature. The beads were collected, washed three times in binding buffer, and eluted using the binding buffer with 1 M NaCl for 10 min on ice. The eluted material was collected, and diluted with the binding buffer without NaCl to reach a final NaCl concentration of 100 mM. The elution was incubated on ice for 1 h then added to RPA-coated ssDNA and incubated for 30 min at room temperature. For TERRA inhibition, either TERRA (UUAGGG) 3 or its derivative (CCCAUU) 3 were incubated with the eluted proteins before their addition to RPAcoated ssDNA. The proteins remaining bound to DNA were analysed by western blot. Identification of the RPA-displacing factors from extracts. Biotinylated ssTEL or ssMUT (20 pmol) was attached to streptavidin-coated beads and coated with recombinant RPA. The RPA-coated ssTEL or ssMUT was incubated with 65 mg of nuclear extract in 500 ml of binding buffer. Beads with no DNA attached were used a negative control. After 30 min of incubation, the beads were retrieved and washed three times with binding buffer containing 300 mM NaCl. The proteins associated with the RPA activity were eluted by binding buffer containing 600 mM NaCl for 10 min on ice. The eluted proteins from ssTEL, ssMUT and naked beads were separated by SDS-PAGE. After the gel was silver-stained, the two ,30-kDa bands specifically captured by RPA-ssTEL were excised and analysed by mass spectrometry. Immunofluorescence analysis. HeLa cells were seeded onto coverslips and cultured overnight. The adhered cells were transfected with POT1 siRNA using oligofectamine (Invitrogen), or with hnRNPA1 siRNA using Lipofectamine RNAi Max (Invitrogen) and cultured for another 48 h. Synchronized cells were treated after 24 h with 2 mM thymidine for 16 h, washed and released, and processed at the indicated time points. Cells were extracted with 0.25% Triton, fixed in 3% paraformaldehyde and further permeablized with 0.5% Triton. Cells were subsequently incubated with the primary antibodies (diluted in PBS containing 3% BSA and 0.05% Tween 20) for 1 h at 37 uC in a humidified chamber. After extensive washing with PBS, cells were incubated with secondary antibodies for 45 min at room temperature, and washed again with PBS. After incubation for 5 min with DAPI, cells were mounted on slides with Vectashield. Slides were analysed using a Nikon H600L fluorescence microscope. Combined immunofluorescence-RNA fluorescence in situ hybridization. Cells were grown on coverslips and collected at different time points 17 h after release of single thymidine block. Cells were washed twice with cold PBS for 5 min and treated with cytobuffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 10 mM PIPES pH 7, 0.1% Triton X-100, 200 mM vanadyl ribonucleoside complex) for 7 min at 4 uC. Cells were rinsed briefly, fixed with 4% paraformaldehyde in PBS (USB 19943) for 10 min at room temperature. Cells were then washed three times with PBS for 5 min each and permeabilized with 0.5% NP40 in PBS for 10 min. Cells were washed twice with PBS for 5 min each and incubated with blocking solution (0.2% fish gelatin and 0.5% BSA) for 1 h. Cells were then incubated with human TRF2 antibody (clone 4A794 Upstate) at 1:2,000 and diluted in blocking solution for 2 h. After washing three times with PBST (PBS containing 0.1% Triton) for 10 min each, the cells were than incubated with secondary antibody Alexa 488 (Invitrogen A11001) at 1:2,000 dilution in blocking solution for 1 h. Cells were washed three times with PBST for 10 min each and were fixed with 4% paraformaldehyde in PBS for 10 min at room temperature. Cells were rinsed briefly with PBS then incubated with hybridization mix (10 nM PNA-TAMRA-(CCCTAA) probe, 50% formamide, 23 SSC, 2 mg ml 21 BSA, 10% dextran sulphate, 10 mM vanadyl ribonucleoside complex) for 18 h in a humidified chamber at 39 uC. Cells were washed with 23 SSC in 50% formamide three times at 39 uC for 5 min each, three times in 23 SSC at 39 uC for 5 min each, and finally once in 23 SSC at room temperature. for 10 min. Coverslips were than mounted on glass microscope slides with Vectashield mounting medium containing DAPI (H-1200). For RNaseA treatment, coverslips were incubated with 200 mg ml 21 RNase A for LETTER RESEARCH
